Hi William.
If you look deeply enough into the actual text of 201.66 there are certain allowances for "small packages" and the FDA defined what they consider a small package in the regulations. Additionally, the regulations do state that if (I think) more than 60% of the total label area would be composed of the Drug Facts box, you have the ability to use alternate labeling (cards, attachments, etc.) or secondary labeling to fully comply. I would also caution that you want to closely check whether your product still meets the requirements for the individual monograph here because there have been some significant and serious changes to the monograph I suspect you are using.
------------------------------
Victor Mencarelli
Director Regulatory Affairs
United States
------------------------------
Original Message:
Sent: 24-Jul-2018 07:45
From: William Bagnasco
Subject: OTC Labeling Requirments
Hello,
I am trying to create the pouch artwork/label for a BZK Towelette, while trying to meet the requirements of 21 CFR 201.66 - Labeling Requirements for OTC Drugs. I am struggling to get all the required information on the pouch, while meeting the minimum font size requirements. Has anyone had any experience with requesting a wavier of labeling requirements from the FDA? How strict is the FDA with enforcing the font size requirements. Will they consider the product misbranded if the font size is too small?
Any insight to this topic would be greatly appreciated.
------------------------------
William Bagnasco
QA/RA Manager
Ronkonkoma NY
United States
------------------------------